Trial Profile
Evaluation of a Supratherapeutic Dose of Intravenous Ceftaroline Fosamil on the QTc Interval
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Apr 2013
Price :
$35
*
At a glance
- Drugs Ceftaroline fosamil (Primary) ; Moxifloxacin
- Indications Bacterial infections; Community-acquired pneumonia; Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
- Focus Pharmacodynamics
- Sponsors Cerexa; Forest Laboratories
- 17 Apr 2013 New trial record